With the advancement of next-generation sequencing (NGS), it is possible to sequence simultaneously all the genes known to be involved in HCM, including GLA gene and the TTR gene involved in Fabry disease and ATTR amyloidosis, respectively. This evidence concerns the gene GLA and Fabry disease.